SX21
Joshua-Safer
Center for Endocrinology, Diabetes, Nutrition & Weight Management - Boston University Medical Center
732 Harrison Avenue, 2nd Floor
Boston, Massachusetts 02118
Phone: 617 638-7470
Fax: 617 638-7449

Joshua D. Safer, MD

Joshua D. Safer is Associate Professor of Medicine and Molecular Medicine at Boston University School of Medicine and director of the Endocrinology Fellowship Training Program. His clinical interests include treatment of thyroid disease and use of hormone therapies. His research is in use of thyroid hormone to treat skin disease and improve wound healing. In addition Dr. Safer serves as an editorial board member for Endocrine Practice, the official journal of the American Association of Clinical Endocrinologists.

Dr. Safer attended college and medical school at the University of Wisconsin in Madison. Dr. Safer moved to Boston to train in endocrinology and did a fellowship in endocrinology at the Harvard Medical School Longwood Program. Dr. Safer spent three years on the faculty at the Beth Israel Deaconess Medical Center and joined the faculty at the Boston University School of Medicine in 1999.

Joshua D. Safer, MD, FACP Director, Endocrinology Fellowship Training and Endocrinology Education Boston University Medical Center Associate Professor of Medicine and Molecular Medicine Boston University School of Medicine Dr. Safer attended college and medical school at the University of Wisconsin in Madison. He spent three years as a fellow in endocrinology at the Harvard Medical School Longwood Program and three years on the faculty at the Beth Israel Deaconess Medical Center. Dr. Safer joined the faculty at the Boston University School of Medicine in 1999. At Boston University, Dr. Safer serves as the director of the endocrinology fellowship training program and the director of the clinical endocrinology course taught in the second year of medical school. Dr. Safer’s research program investigates the potential to treat skin disease with thyroid hormone based creams. Dr. Safer’s clinical practice emphasizes both thyroid disease and sex hormone treatment.

Support SX21

For the first time in history, advances in medicine and technology are liberating human beings from the silent despair of sexual dysfunction – a growing epidemic that affects over 30% of Americans regardless of gender, age or status. With your generous support, we can continue to do important research into treatments, raise awareness, and provide valuable resources like this website. Thanks for your help.

Make a Donation